BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 36465301)

  • 1. Differences between users' and addiction medicine experts' harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates.
    Bonnet U; Specka M; Kanti AK; Scherbaum N
    Front Psychiatry; 2022; 13():1041762. PubMed ID: 36465301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative Harm/Benefit Analysis of Various Psychotropic Substances from the Perspective of German Drug Users and Addiction Medicine Experts - A Contribution to Psychoeducation of Substance-Addicted Individuals and Restriction/Legalization Debates].
    Kanti AK; Specka M; Scherbaum N; Bonnet U
    Fortschr Neurol Psychiatr; 2022 Dec; ():. PubMed ID: 36522164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Weighing the benefits and harms of psychotropic and analgesic substances - A perspective of German addiction medicine experts].
    Bonnet U; Specka M; Soyka M; Alberti T; Bender S; Hilger J; Hillemacher T; Kuhlmann T; Kuhn J; Lüdecke C; Reimer J; Schneider U; Schroeder W; Stuppe M; Wiesbeck G; Wodarz N; Scherbaum N
    Fortschr Neurol Psychiatr; 2022 Jan; 90(1-02):19-29. PubMed ID: 33634461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ranking the Harm of Psychoactive Drugs Including Prescription Analgesics to Users and Others-A Perspective of German Addiction Medicine Experts.
    Bonnet U; Specka M; Soyka M; Alberti T; Bender S; Grigoleit T; Hermle L; Hilger J; Hillemacher T; Kuhlmann T; Kuhn J; Luckhaus C; Lüdecke C; Reimer J; Schneider U; Schroeder W; Stuppe M; Wiesbeck GA; Wodarz N; McAnally H; Scherbaum N
    Front Psychiatry; 2020; 11():592199. PubMed ID: 33192740
    [No Abstract]   [Full Text] [Related]  

  • 5. Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users.
    Morgan CJ; Noronha LA; Muetzelfeldt M; Feilding A; Curran HV
    J Psychopharmacol; 2013 Jun; 27(6):497-506. PubMed ID: 23438502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users.
    Shapira B; Rosca P; Berkovitz R; Gorjaltsan I; Neumark Y
    PeerJ; 2020; 8():e9461. PubMed ID: 32742781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment.
    Specka M; Kuhlmann T; Sawazki J; Bonnet U; Steinert R; Cybulska-Rycicki M; Eich H; Zeiske B; Niedersteberg A; Schaaf L; Scherbaum N
    Front Psychiatry; 2020; 11():569. PubMed ID: 32733288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Snapshot of narcotic drugs and psychoactive substances in Kuwait: analysis of illicit drugs use in Kuwait from 2015 to 2018.
    Al-Matrouk A; Al-Hasan M; Naqi H; Al-Abkal N; Mohammed H; Haider M; Al-Shammeri D; Bojbarah H
    BMC Public Health; 2021 Apr; 21(1):671. PubMed ID: 33827491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden.
    Richert T; Johnson B
    Harm Reduct J; 2013 Oct; 10():27. PubMed ID: 24139199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance use during the COVID-19 pandemic: What is really happening?
    Mellos E; Paparrigopoulos T
    Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the impact of a major electronic music festival on the consumption patterns of illicit and licit psychoactive substances in a Mediterranean city using wastewater analysis.
    Senta I; Krizman-Matasic I; Kostanjevecki P; Gonzalez-Mariño I; Rodil R; Quintana JB; Mikac I; Terzic S; Ahel M
    Sci Total Environ; 2023 Sep; 892():164547. PubMed ID: 37270014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Fatal Poisoning Among Drug Users in France From 2011 to 2021: An Analysis of the DRAMES Register.
    Revol B; Willeman T; Manceau M; Dumestre-Toulet V; Gaulier JM; Fouilhé Sam-Laï N; Eysseric-Guérin H;
    JAMA Netw Open; 2023 Aug; 6(8):e2331398. PubMed ID: 37647066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived harmfulness of substance use: a pilot study.
    Sarkar S; Balachander S; Basu D
    Indian J Community Med; 2014 Jan; 39(1):26-9. PubMed ID: 24696536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Licit and Illicit Drugs Use during Pregnancy in Mexican Women.
    Gómez-Ruiz LM; Marchei E; Rotolo MC; Brunetti P; Mannocchi G; Acosta-López A; Ramos-Gutiérrez RY; Varela-Busaka MB; Pichini S; Garcia-Algar O
    Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of cathinones and other new psychoactive substances in hair of parents and children of families with known or suspected parental abuse of conventional illegal drugs.
    Niebel A; Pragst F; Krumbiegel F; Hartwig S
    Forensic Sci Int; 2022 Feb; 331():111148. PubMed ID: 34923263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of changes in illicit drugs, alcohol, and nicotine consumption during Ramadan via wastewater analysis.
    Guzel EY
    Environ Sci Pollut Res Int; 2022 Dec; 29(59):89245-89254. PubMed ID: 35851933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Monitoring of Psychoactive Substances in Psychiatric Patients Using Liquid Chromatography-High-Resolution Mass Spectrometry: A Key Tool for Treatment Planning and Understanding Consumption Patterns in Rome, Italy.
    La Maida N; Di Giorgi A; Pichini S; Pellegrini M; Di Trana A; Elmo MG; Polselli GM; Casella P; Di Stefano A; Ducci G
    Ther Drug Monit; 2024 Apr; 46(2):203-209. PubMed ID: 38018870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Substance use, affective problems and personality traits: test of two association models].
    Chakroun N; Doron J; Swendsen J
    Encephale; 2004; 30(6):564-9. PubMed ID: 15738859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New psychoactive substances in Taiwan: The current situation and initiative for rational scheduling.
    Yu WJ; Cottler L; Li JH
    J Food Drug Anal; 2021 Mar; 29(1):168-181. PubMed ID: 35696229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harms associated with psychoactive substances: findings of the UK National Drug Survey.
    Morgan CJ; Muetzelfeldt L; Muetzelfeldt M; Nutt DJ; Curran HV
    J Psychopharmacol; 2010 Feb; 24(2):147-53. PubMed ID: 19939875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.